BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 28251974)

  • 1. [Systemic delivery of complexes of melanoma RNA with mannosylated liposomes activates highly efficient murine melanoma-specific cytotoxic T cells in vivo].
    Markov OV; Mironova NL; Shmendel EV; Maslov MA; Zenkova MA
    Mol Biol (Mosk); 2017; 51(1):118-125. PubMed ID: 28251974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multicomponent mannose-containing liposomes efficiently deliver RNA in murine immature dendritic cells and provide productive anti-tumour response in murine melanoma model.
    Markov OV; Mironova NL; Shmendel EV; Serikov RN; Morozova NG; Maslov MA; Vlassov VV; Zenkova MA
    J Control Release; 2015 Sep; 213():45-56. PubMed ID: 26134071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel cationic liposomes provide highly efficient delivery of DNA and RNA into dendritic cell progenitors and their immature offsets.
    Markov OO; Mironova NL; Maslov MA; Petukhov IA; Morozova NG; Vlassov VV; Zenkova MA
    J Control Release; 2012 Jun; 160(2):200-10. PubMed ID: 22155599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prophylactic Dendritic Cell-Based Vaccines Efficiently Inhibit Metastases in Murine Metastatic Melanoma.
    Markov OV; Mironova NL; Sennikov SV; Vlassov VV; Zenkova MA
    PLoS One; 2015; 10(9):e0136911. PubMed ID: 26325576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting dendritic cells with antigen-containing liposomes: a highly effective procedure for induction of antitumor immunity and for tumor immunotherapy.
    van Broekhoven CL; Parish CR; Demangel C; Britton WJ; Altin JG
    Cancer Res; 2004 Jun; 64(12):4357-65. PubMed ID: 15205352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The enhanced antitumor-specific immune response with mannose- and CpG-ODN-coated liposomes delivering TRP2 peptide.
    Lai C; Duan S; Ye F; Hou X; Li X; Zhao J; Yu X; Hu Z; Tang Z; Mo F; Yang X; Lu X
    Theranostics; 2018; 8(6):1723-1739. PubMed ID: 29556352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancement of dendritic cells transfection in vivo and of vaccination against B16F10 melanoma with mannosylated histidylated lipopolyplexes loaded with tumor antigen messenger RNA.
    Perche F; Benvegnu T; Berchel M; Lebegue L; Pichon C; Jaffrès PA; Midoux P
    Nanomedicine; 2011 Aug; 7(4):445-53. PubMed ID: 21220051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced DNA vaccine potency by mannosylated lipoplex after intraperitoneal administration.
    Hattori Y; Kawakami S; Lu Y; Nakamura K; Yamashita F; Hashida M
    J Gene Med; 2006 Jul; 8(7):824-34. PubMed ID: 16625665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of Lipid Composition of Cationic Liposomes 2X3-DOPE on mRNA Delivery into Eukaryotic Cells.
    Vysochinskaya V; Shishlyannikov S; Zabrodskaya Y; Shmendel E; Klotchenko S; Dobrovolskaya O; Gavrilova N; Makarova D; Plotnikova M; Elpaeva E; Gorshkov A; Moshkoff D; Maslov M; Vasin A
    Pharmaceutics; 2022 Dec; 15(1):. PubMed ID: 36678637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liposomes-coated gold nanocages with antigens and adjuvants targeted delivery to dendritic cells for enhancing antitumor immune response.
    Liang R; Xie J; Li J; Wang K; Liu L; Gao Y; Hussain M; Shen G; Zhu J; Tao J
    Biomaterials; 2017 Dec; 149():41-50. PubMed ID: 28992509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of an antigen-presenting cell-targeted DNA vaccine against melanoma by mannosylated liposomes.
    Lu Y; Kawakami S; Yamashita F; Hashida M
    Biomaterials; 2007 Jul; 28(21):3255-62. PubMed ID: 17449093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prophylactic immunization with Bubble liposomes and ultrasound-treated dendritic cells provided a four-fold decrease in the frequency of melanoma lung metastasis.
    Oda Y; Suzuki R; Otake S; Nishiie N; Hirata K; Koshima R; Nomura T; Utoguchi N; Kudo N; Tachibana K; Maruyama K
    J Control Release; 2012 Jun; 160(2):362-6. PubMed ID: 22192573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of antitumor immunity with dendritic cells transduced with adenovirus vector-encoding endogenous tumor-associated antigens.
    Kaplan JM; Yu Q; Piraino ST; Pennington SE; Shankara S; Woodworth LA; Roberts BL
    J Immunol; 1999 Jul; 163(2):699-707. PubMed ID: 10395660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Strategies for antigen loading of dendritic cells to enhance the antitumor immune response.
    Strome SE; Voss S; Wilcox R; Wakefield TL; Tamada K; Flies D; Chapoval A; Lu J; Kasperbauer JL; Padley D; Vile R; Gastineau D; Wettstein P; Chen L
    Cancer Res; 2002 Mar; 62(6):1884-9. PubMed ID: 11912169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Truncated TERT mRNA transfected dendritic cells evoke TERT specific antitumor response in vivo.
    Qiu J; Lil GW; Sui YF; Sun YJ; Huang YY; Si SY; Ge W; Song HP
    Hepatogastroenterology; 2007; 54(75):681-7. PubMed ID: 17591041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biodistribution and vaccine efficiency of murine dendritic cells are dependent on the route of administration.
    Eggert AA; Schreurs MW; Boerman OC; Oyen WJ; de Boer AJ; Punt CJ; Figdor CG; Adema GJ
    Cancer Res; 1999 Jul; 59(14):3340-5. PubMed ID: 10416590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cationic liposomes loaded with a synthetic long peptide and poly(I:C): a defined adjuvanted vaccine for induction of antigen-specific T cell cytotoxicity.
    Varypataki EM; van der Maaden K; Bouwstra J; Ossendorp F; Jiskoot W
    AAPS J; 2015 Jan; 17(1):216-26. PubMed ID: 25387996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor-associated antigen/IL-21-transduced dendritic cell vaccines enhance immunity and inhibit immunosuppressive cells in metastatic melanoma.
    Aravindaram K; Wang PH; Yin SY; Yang NS
    Gene Ther; 2014 May; 21(5):457-67. PubMed ID: 24572790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A generic RNA pulsed DC based approach for developing therapeutic intervention against nasopharyngeal carcinoma.
    Tyagi RK; Parmar R; Patel N
    Hum Vaccin Immunother; 2017 Apr; 13(4):854-866. PubMed ID: 27901642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapy of established B16-F10 melanoma tumors by a single vaccination of CTL/T helper peptides in VacciMax.
    Mansour M; Pohajdak B; Kast WM; Fuentes-Ortega A; Korets-Smith E; Weir GM; Brown RG; Daftarian P
    J Transl Med; 2007 Apr; 5():20. PubMed ID: 17451606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.